Literature DB >> 14712275

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Thorsten R Mempel1, Sarah E Henrickson, Ulrich H Von Andrian.   

Abstract

Primary T-cell responses in lymph nodes (LNs) require contact-dependent information exchange between T cells and dendritic cells (DCs). Because lymphocytes continually enter and leave normal LNs, the resident lymphocyte pool is composed of non-synchronized cells with different dwell times that display heterogeneous behaviour in mouse LNs in vitro. Here we employ two-photon microscopy in vivo to study antigen-presenting DCs and naive T cells whose dwell time in LNs was synchronized. During the first 8 h after entering from the blood, T cells underwent multiple short encounters with DCs, progressively decreased their motility, and upregulated activation markers. During the subsequent 12 h T cells formed long-lasting stable conjugates with DCs and began to secrete interleukin-2 and interferon-gamma. On the second day, coinciding with the onset of proliferation, T cells resumed their rapid migration and short DC contacts. Thus, T-cell priming by DCs occurs in three successive stages: transient serial encounters during the first activation phase are followed by a second phase of stable contacts culminating in cytokine production, which makes a transition into a third phase of high motility and rapid proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712275     DOI: 10.1038/nature02238

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  697 in total

1.  Chrysalis: A New Method for High-Throughput Histo-Cytometry Analysis of Images and Movies.

Authors:  Dmitri I Kotov; Thomas Pengo; Jason S Mitchell; Matthew J Gastinger; Marc K Jenkins
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  Duration of antigen receptor signaling determines T-cell tolerance or activation.

Authors:  Shoshana D Katzman; William E O'Gorman; Alejandro V Villarino; Eugenio Gallo; Rachel S Friedman; Matthew F Krummel; Garry P Nolan; Abul K Abbas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 3.  Lipid-based patterning of the immunological synapse.

Authors:  Morgan Huse
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

4.  ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Robin Kageyama; Danelle Eto; Tania C Escobar; Robert J Johnston; Laurel Monticelli; Christopher Lao; Shane Crotty
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

5.  Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Authors:  Sten-Erik Bergström; Mehmet Uzunel; Toomas Talme; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 6.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

7.  Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.

Authors:  Nitasha A Kumar; Renee M van der Sluis; Talia Mota; Rachel Pascoe; Vanessa A Evans; Sharon R Lewin; Paul U Cameron
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

8.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro.

Authors:  Chuda Chittasupho; Joshua Sestak; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  Mol Pharm       Date:  2013-12-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.